Another important observation was that in AP-treated schizophrenia subjects, permissive H4K16ac at ADRA2A promoter was significantly higher than in matched controls whereas it remained unaltered in AP-free schizophrenia subjects. The gene discussed is ADRA2A; the disease is schizophrenia.